Mother's body size and placental size predict heart disease in men

June 2, 2011 in Cardiology

Researchers investigating the foetal origins of chronic disease have discovered that combinations of a mother's body size and the shape and size of her baby's placenta can predict heart disease in men in later life. The research is published online today in the European Heart Journal.

Professor David Barker and colleagues studied 6975 men born in Helsinki (Finland) between 1934-1944 – a time when not only was the babies' size at birth recorded but also the size of the placental surface. Other available information included details of the mothers' height and weight in late pregnancy, age, parity, and date of last menstrual period.

They found that there were three combinations of mother's body size and placental shape and size that predicted coronary in boys when they reached late adulthood (from about aged 40 onwards):

  1. An oval-shaped placental surface in short mothers who had not been pregnant before – the narrower the placental surface in relation to its length, the more the risk of heart disease rose, increasing by 14% for each centimetre increase in the difference between the length and breadth of the surface.
  2. A small placental surface in tall, heavy women (those with a body mass index (BMI) over 26 kg/m2, the middle value for the women in the study); in these men their risk of heart disease rose by a quarter (25%) per 40cm2 decrease in the surface area.
  3. A large placental weight in relation to birthweight in babies born to tall mothers with a BMI below 26 kg/m2; these men had a seven percent increased risk for every one percent larger ratio of placental weight to birthweight.
The associations were independent of the social class of the men or the family into which they were born.

Prof Barker, who is Professor of Clinical Epidemiology at the University of Southampton (UK) and Professor in Cardiovascular Medicine at Oregon Health and Science University (USA), has already discovered that there is a link between placental weight and heart disease in later live, but placental weight does not indicate the size of the surface that is available for absorbing and delivering nutrients for the growing baby. "Due to the fact that the shape and size as well as the weight of the placenta were routinely measured at the birth of this group of men, we have been able to show for the first time that a combination of the mother's body size and the shape and size of the placental surface predicts later heart disease," he said.

For each of the three combinations, the babies that developed heart disease in later life tended to be thinner than average, which indicated that they were undernourished at birth.

Prof Barker said that he thought the explanation for the first combination (oval placental surface in women who have not been pregnant before) is that "an oval placental surface is an indication that the implantation of the placenta was disrupted in early pregnancy, leading to foetal under-nutrition, which, in turn, programmes coronary heart disease in later life". The mechanisms that may play a role in disrupting the implantation of the placenta are not yet fully understood.

For the second combination (small placental surface in tall, heavy women), Prof Barker said: "Although the mother is tall and has a BMI of over 26 kg/m2, indicating that she was well-nourished at the time of her pregnancy, placental growth depends on the structure and function of the mother's uterine wall, which is established during her own foetal life. Therefore, her own foetal experience necessarily affects placentation in her offspring. Foetal growth depends on the availability of nutrients. Restricted placental growth may, paradoxically, have a greater effect in babies who are growing rapidly because their mothers are well-nourished. We think that these babies were able to grow rapidly at first, but the small placenta started to restrict their growth mid-gestation, so that by the time they were born, they were under-nourished."

For the third combination (large placental weight in relation to birthweight in babies born to tall women below the average weight), Prof Barker believes the explanation lies in what the mother ate during pregnancy. "Tallness indicates good nutrition before pregnancy, but their low body mass index indicates poor nutrition during pregnancy," he said.

Prof Barker says that this research is further evidence of the long-term effect of foetal development. "Chronic disease is the product of a mother's lifetime nutrition and the early growth of her child. It is not simply a consequence of poor lifestyles in later life. Rather it is a result of variations in the normal processes of human development."

Now the researchers plan to study the diets and body characteristics ( and shape, fat and lean mass) of pregnant women, the growth patterns of their babies before birth using ultrasound, and the placentas of their offspring. They hope to discover the links between the mother, her baby's and the development of the baby's cardiovascular system in ways that lead to poor liver and vascular function – two of the primary culprits for heart disease in later life.

More information: "Mother's body size and placental size predict coronary heart disease in men". European Heart Journal. doi:10.1093/eurheartj/ehr147

Provided by European Society of Cardiology search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts
  • a numerical problem...kindly provide d solution
    created9 hours ago
  • energy and momentum conservation
    created9 hours ago
  • Uniform circular motion (centripetal acceleration & force)
    created11 hours ago
  • Rotational Mechanics: Sphere collision problem
    created17 hours ago
  • Combustion Model
    created17 hours ago
  • Properties of Cathode Rays
    created17 hours ago
  • More from Physics Forums - Classical Physics

More news stories

Low vitamin D in diet increases stroke risk in Japanese-Americans

Japanese-American men who did not eat foods rich in vitamin D had a higher risk of stroke later in life, according to results of a 34-year study reported in Stroke, an American Heart Association journal.

Cardiology created 5 hours ago | popularity not rated yet | comments 0

Clot buster seems to help up to 6 hours after stroke

(HealthDay) -- The largest study of its kind finds that stroke patients benefit from a clot-busting drug even six hours after a stroke, suggesting that the current recommended 4.5-hour limit could be expanded.

Cardiology created 16 hours ago | popularity not rated yet | comments 0

Calcium supplements linked to significantly increased heart attack risk

Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart.

Cardiology created May 23, 2012 | popularity not rated yet | comments 1 | with audio podcast

New study confirms value of cardiac output monitor

(Medical Xpress) -- A new Australian study has confirmed the accuracy of a modern non-invasive cardiac output monitor that can replace a 40-year-old standard in this field.

Cardiology created May 23, 2012 | popularity not rated yet | comments 0

Scientists turn patients' skin cells into heart muscle cells to repair their damaged hearts

For the first time scientists have succeeded in taking skin cells from heart failure patients and reprogramming them to transform into healthy, new heart muscle cells that are capable of integrating with existing heart tissue.

Cardiology created May 23, 2012 | popularity 5 / 5 (2) | comments 0 | with audio podcast


Amino acid consumption associated with how fast cancer cells divide

For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...

'Personality genes' may help account for longevity

"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...

Gene discovery points towards non-hormonal male contraceptive

A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

Cyber exercise partners help you go the distance: Motivation gains can double

A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation – by as much as 100 percent – ...

Brentuximab vedotin effective in large-cell lymphoma

(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...